Red Blood Cell Substitutes: Microencapsulated Hemoglobin and Cross-Linked Hemoglobin Including Pyridoxylated Polyhemoglobin & Conjugated Hemoglobin

References

• Amberson WR. Blood substitute. Biol. Rev. 1937; 12: 48
   Google Scholar
• Rabiner S F, Helbert J R, Lopas H, Friedman LH. Evaluation of stroma free hemoglobin solution as a plasma expander. J Exp Med 1967; 126: 1127
   PubMed Web of Science ®Google Scholar
• Moss G S, De Woskin R, Rosen A L, Levine H, Palani CK. Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet 1976; 142: 357
   PubMedGoogle Scholar
• DcVenuto F, Zuck T F, Zegna A I, Moores WY. Characteristics of stromafree hemoglobin prepared by crystallization. J Lab Clin Med 1977; 89: 509
   PubMedGoogle Scholar
• Savitsky J P, Doozi J, Black J, Arnold JD. A clinical safety trial of stroma free hemoglobin. Clin Pharm Ther 1978; 23: 73
   PubMed Web of Science ®Google Scholar
• Chang T MS. Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology. McGill University. 1957; 1–25
   Google Scholar
• Chang T MS. Semipermeable microcapsules. Science 1964; 146(3643)524
   PubMed Web of Science ®Google Scholar
• Chang T MS. Semipermeable aqueous microcapsules (Ph.D. Thesis). McGill University, MontrealCanada 1965
   Google Scholar
• Chang T MS, Macintosh F C, Mason SG. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 1966; 44: 115–128
   PubMed Web of Science ®Google Scholar
• Chang T MS. Lipid-coated spherical ultrathin membranes of polymer cross-linked protein as possible cell membrane models. Fed. Proc. (abstract). 1969; 28: 461
   Google Scholar
• Chang T MS, Macintosh F C, Mason SG. Encapsulated hydrophilic compositions and methods of making them. Canadian Patent 1971; 873: 815
   Google Scholar
• Chang T MS. Artificial cells. Charles C Thomas, Springfield, IL 1972
   Google Scholar
• Chang T MS. Artificial cells: biotechnology and medical applications. Appl Biochem & Biotechnol 1984; 10: 5
   PubMed Web of Science ®Google Scholar
• Chang T MS. Artificial red blood cells. Trans. Am. Soc. Artif. Int. Organs 1980; 26: 354–357
   Google Scholar
• Djordjevich L, Miller I. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp. Hematol. 1980; 8: 584
   PubMed Web of Science ®Google Scholar
• Hunt A C, Burnette RR. Neohemocytes. In Advances in Blood Substitute Research, RB Bolin, RP Geyer, GJ Nemo. Alan R Liss Inc, New York 1983; 59–70
   Google Scholar
• Gaber B P, Farmer MC. Encapsulation of hemoglobin in phospholipid vesicles: preparation and properties of a red blood cell surrogate. Prog. Clin. Biol. Res. 1984; 165: 179–190
   PubMedGoogle Scholar
• Bunn H F, Jandl JH. The renal handling of hemoglobin. Trans Assoc Am Physicians 1968; 81: 147
   PubMedGoogle Scholar
• Mok W, Chen D E, Mazur A. Covalent linkage of subunits of hemoglobin. Fed Proc 1975; 34: 1458
   PubMedGoogle Scholar
• Benesch R, Benesch R E, Yung S, Edalji R. Hemoglobin covalently bridged across the polyphosphate binding site. Biochem Biophys Res Commun 1975; 63: 1123
   PubMed Web of Science ®Google Scholar
• Greenburg A G, Hayashi R, Krupenas I. Intravascular persistence and oxygen delivery of pyridoxalated stroma-free hemoglobin during gradations of hypotension. Surgery 1979; 86: 13
   PubMed Web of Science ®Google Scholar
• Bakker J C, Bleeker WK, Van der Plas J. Hemoglobin interdimerically cross-linked with NFPLP. J. Biomat. Artificial Cells and Artificial Organs 1987; 15: 343
   Google Scholar
• Dudziak R, Bonhard K. The development of hemoglobin preparations for various indications. Anesthesist 1980; 29: 181
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Zegna AI. Blood exchange with pyridoxalated-polymerized hemoglobin. Surg Gynecol Obstet 1982; 155: 342
   PubMedGoogle Scholar
• Kcipert P E, Minkowitz J, Chang T MS. Cross-linked stroma-free polyhemoglobin as a potential blood substitute. Int. J. Artif. Organs 1982; 5(6)383
   PubMedGoogle Scholar
• Sehgal L R, Rosen A L, Gould S A, Sehgal H L, Dalton L, Mayoral J, Moss GS. In vitro and in vivo characteristics of polymerized pyridoxalated hemoglobin solution. Fed Proc 1980; 39: 2383
   Google Scholar
• Sehgal L R, Gould S A, Rosen A L, Sehgal H L, Moss GS. Polymerized pyridoxalated hemoglobin: a red cell substitute with normal oxygen capacity. Surgery 1984; 95(4)433
   PubMed Web of Science ®Google Scholar
• Keipert P E, Chang T MS. In vivo assessment of pyridoxalated cross-linked polyhemoglobin as an artificial red cell substitute in rats Trans. Am. Soc. Artif. Intern. Organs 1983; 29: 329
   PubMedGoogle Scholar
• Keipert P E, Chang T MS. Preparation and in-vitro characteristics of pyridoxalated polyhemoglobin as blood substitute. Appl Biochem & Biotechnol 1984; 10: 133
   PubMed Web of Science ®Google Scholar
• Keipert P E, Chang T MS. pyridoxalated polyhemoglobin as a blood substitute for resuscitation of lethal hemorrhagic shock in conscious rats. Biomat. Med. Dev. Artif. Organs 1985; 13: 1–15
   PubMedGoogle Scholar
• Hobbhahn J, Vogel H, Kothe N, Brendel W, Keipert P, Jesch F. Hemodynamics and transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs. Acta Anesth. Scand. 1985; 29: 537–543
   PubMed Web of Science ®Google Scholar
• Kiepert P E, Chang T MS. Effects of partial and total isovolemic exchange transfusion in fully conscious rats using pyridoxylated polyhemoglobin solution as a colloidal oxygen delivering blood replacement fluid. Vox Sang 1987; 53: 7–14
   PubMedGoogle Scholar
• Ning J, Chang T MS. Effects of stroma-free hemoglobin and polyhomoglobin on blood cells, complement activation and coagulation facts in rats. J. Biomat. Artificial Cells, Artificial Organs. 1987; 15: 380
   Google Scholar
• Marks DH, Patressi J, Chaudry IT. Effects of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system. Circ. Shock. 1985; 16: 165–172
   PubMedGoogle Scholar
• Hertzman C M, Keipert P E, Chang T MS. Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report. Int. J. Artif. Organs 1986; 9: 179–182
   PubMed Web of Science ®Google Scholar
• Chang T MS, Varma R. Pyridoxalated heterogenous and homologous polyhemoglobin and hemoglobin: systemic effects of replacement transfusion in rats previously received immunising doses. Biomaterial, Artificial Cells and Artificial Organs. 1987; 15
   Google Scholar
• Vogel W M, Dennis R C, Cassidy G, Apstein C S, Valeri CR. Am. J. Physiol. 1986; 251: H413–H420
   PubMed Web of Science ®Google Scholar
• Hsia J C, Hayes TM. Separation of glyoxylated hemoglobin with varying oxygen affinity by polyanion fast protein liquid chromatography. J. Chromatography 1984; 303: 425
   PubMedGoogle Scholar
• Tarn S C, Blumenstein J, Wong JT. Dextran hemoglobin. Proc. Natl Acad Sci USA 1976; 73: 2128
   PubMed Web of Science ®Google Scholar
• Ayisaku K, Iwashita Y. Biochcm Biophys Res. Comm. 1980; 97: 1076–1081
   PubMedGoogle Scholar
• Iwasaki K, Iwashita K. Preparation and evaluation of hemoglobin polyethylene glycol conjugate (pyridoxylated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artificial Organs 1986; 10: 411–416
   PubMed Web of Science ®Google Scholar
• Feola M, Gonzalez H, Canizaro P C, Bingham D. Development of bovine stroma-free hemoglobin solution as a blood substitute. Surgery Gynecology & Obstetrics 1983; 157: 399
   PubMedGoogle Scholar
• De Varennes B, Chang T MS, Symes J F, Guerraty TA. Isolated heart preservation for 24 hours: is O4 important. J. Biomat. Artificial Cells and Artificial Organs 1987; 15: 663, 4410
   Google Scholar
• Maffuid P W, Greenburg A G, Lee E S, Velky T, Hoyt DB. Modification of stroma free hemoglobin: chemistry and efficacy. Am. College. Surg. Forum 1983; 34: 5
   Google Scholar
• Winslow R. M. This symposium volume
   Google Scholar
• Tsuchida E. Ann. New York Acad. Sci. 1985; 446: 429
   PubMed Web of Science ®Google Scholar